Skip to Main Content

Try STAT+ TODAY

depression

Most Read

Health Tech By Mario Aguilar

Are smartphones making us miserable? A Google study aims to find out

CDC_MONKEYPOX

Health By Helen Branswell

EU health agency warns monkeypox could become endemic in Europe if outbreak continues

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and BioNTech seek Covid-vaccine use in kids under 5; Pfizer refunds $290,000 over misleading coupons

Childhood vaccines

Health By Helen Branswell

Pfizer/BioNTech to seek Covid vaccine authorization for children under age 5

First Opinion By Marc Succi

Immersion in innovation should be part of every health care professional’s training

In the Lab By Megan Molteni

Buffalo shooting ignites a debate over the role of genetics researchers in white supremacist ideology

OrigamiBoats_Illustration_MollyFerguson_051822

A STAT Investigation By Casey Ross

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

Pharmalot By Ed Silverman

Pfizer to refund $290,000 to consumers in four states over misleading copay coupons

All Coverage

DNA sequence

In the Lab By Associated Press

23andMe data points to genes affecting depression risk

Neuron

Biotech By Meghana Keshavan

How tinkering with a mellow messenger in the brain could yield new drugs

advertisement

First Opinion By Joan M. Anzia

It’s time to recognize and prevent the tragedy of physician suicide

PhysicianSuicide

Health By Judith Graham

Why are doctors plagued by depression and suicide? A crisis comes into focus

Hyperthermia

Health By Eric Boodman

Can a stint in the ‘fever machine’ treat depression?

Pregnant woman

Biotech By Meghana Keshavan and Damian Garde

Experimental drug shows promise for quick treatment of postpartum depression

Depression

First Opinion By Peter D. Kramer

Excavating the truth about who benefits from antidepressants

Prozac

Health By Karen Weintraub

Most antidepressants don’t work on kids and teens, study finds

ECT Machine

First Opinion By Kate G. Farber and Charles H. Kellner

Don’t call electroconvulsive therapy ‘shock therapy’

MAGIC MUSHROOMS

Health By Andrew Joseph

Magic mushroom ingredient offers hope for treating depression

PHQ-9 Depression questionairre

Health By Leah Samuel

Hospitals scramble to offer mental health care for depressed physicians

Omega 3

Quick Take By Megan Thielking

Nutritional supplements boost mood in patients taking antidepressants

Suicide Barrier

Quick Take By Leah Samuel

Suicide rates are rising steeply, especially among middle-aged whites

transcranial magnetic stimulation

Health By Joseph P. Kahn — Boston Globe

Tracking the risks and rewards of transcranial magnetic stimulation

ECT Clinic

Health By Judith Graham

Psychiatric shock therapy, long controversial, may face fresh restrictions

Heart monitor

Quick Take By Eric Boodman

The science of heartbreak: A loved one’s death boosts risk of cardiac arrhythmia

Business By Rebecca Robbins

FDA rejects bid to market antidepressant to treat foggy thinking

Depression

First Opinion By Patrick Skerrett

Depression screening for adults and adolescents has benefits, but don’t ignore the downsides

Cognitive dysfunction

Business By Rebecca Robbins

This antidepressant may be no better than cheaper alternatives. But demand could soon soar

Business By Asher Mullard

Could a drug that tamps down inflammation lift the fog of depression?

Ketamine crystals

In the Lab By Megan Thielking

Scientists seek fast-acting antidepressant, from ketamine to laughing gas

Anti-Depressants medications

Lab Chat By Megan Thielking

Lab Chat: Tailoring depression treatment using a blood test

Winter sunset

Gut Check By Sharon Begley

Christmas suicide surge is a myth, but what about the January rebound?

Pregnant woman medication

Gut Check By Sharon Begley

Do antidepressants during pregnancy increase baby’s autism risk?

First Opinion By Frances Southwick

‘A painful facade’: My battle with depression as a medical resident